Das Agonisten-Protokoll bei der ovariellen Stimulation
摘要
The use of gonadotropin-releasing hormone (GnRH) agonists has declined sharply in Germany over the past 18 years, both in the long and the short protocol. Nevertheless, above-average pregnancy rates have been observed—compared to the antagonist protocol. There are many reasons for this. One aspect is the significantly lower risk of overstimulation in the antagonist protocol.